EUVIMEDEUVIMED entdecken
Multizentrische StudieRandomisierte kontrollierte StudieVergleichsstudie

Rationales Behind Physiology-Guided Revascularization

Rui Zhang, Hao-Yu Wang, Lei Song, Changdong Guan, Dong Yin, Chenggang Zhu, Lei Feng, Zening Jin, Bo Yu, Guosheng Fu, Yujie Zhou, Jian'an Wang und 12 weitere

JACC: Cardiovascular Interventions · 2026

DOI: 10.1016/j.jcin.2025.10.042 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift JACC: Cardiovascular Interventions, 2026. Verfasst von Rui Zhang und 23 weiteren Autor:innen. Beteiligte Einrichtung: Cardiometabolic Medicine Center, National Clinical Research Center for Cardiovascular Diseases, Fuwai Hospital, National Center for Cardiovascular Di…. Hauptthemen laut MEDLINE: Percutaneous Coronary Intervention, Coronary Angiography, Coronary Artery Disease, Fractional Flow Reserve, Myocardial. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 23 Literaturangaben. Gefördert von: CAMS, National Natural Science Foundation of China, Beijing Municipal Health Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The optimization of a treatment plan developed on the basis of coronary angiography alone is recognized as one of the underlying rationales for the clinical benefits of physiology-guided percutaneous coronary intervention (PCI). OBJECTIVES: The aim of this study was to investigate the diagnostic impact of quantitative flow ratio (QFR) through a post hoc analysis of the multicenter randomized FAVOR (Comparison of Quantitative Flow Ratio Guided and Angiography Guided Percutaneous Intervention in Patients With Coronary Artery Disease) III China trial. METHODS: In FAVOR III China, operators were required to declare all target vessels intended for PCI before randomization (prerandomization declared treatment plan). After randomization, the actual treatment strategy was performed with online QFR or angiographic guidance (randomized allocation). In this study, prerandomization treatment plan and postrandomization treatment strategy were adjudicated using off-line QFR by independent core laboratory to determine physiological concordance. The primary outcome of interest for the present study was major adverse cardiac events. RESULTS: Among 3,768 pooled patients with available off-line QFR, 2,601 (69.0%) had prerandomization physiology-concordant plans, proportions of which were comparable between the online QFR-guided and angiography-guided groups (70.9% [1,340 of 1,891] vs 67.2% [1,261 of 1,877], standardized mean difference = 0.087). Physiological concordance was reclassified in 447 (23.6%) and 87 (4.6%) patients with online QFR and angiographic guidance, respectively, and a significant between-group difference was identified in terms of achieving postrandomization physiological concordance (92.3% vs 67.2%, standardized mean difference = 0.665). A significant interaction was identified between prerandomization physiological concordance and randomized allocation for 2-year major adverse cardiac events (P for interaction = 0.002). Patients with older age, multivessel disease, left circumflex or right coronary artery involved, and lower SYNTAX (Synergy Between PCI With Taxus and Cardiac Surgery) scores were found more likely to have prerandomization physiological nonconcordance. CONCLUSIONS: In the FAVOR III China trial, approximately 30% of patients showed discrepancies between angiography-based treatment plans and physiological ischemia. The mechanistic insight underlying the benefits of QFR-guided PCI is reclassification following online QFR guidance, which leads to a shift from initially flawed plans toward physiology-concordant decisions. (The FAVOR III China Study [FAVORIII]; NCT03656848).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Percutaneous Coronary InterventionCoronary AngiographyCoronary Artery DiseaseFractional Flow Reserve, MyocardialCoronary VesselsCardiac CatheterizationCoronary CirculationHumansMaleFemaleMiddle AgedChinaTreatment OutcomeAgedPredictive Value of TestsRisk FactorsTime FactorsClinical Decision-Making

Stichwörter der Autor:innen

angiographypercutaneous coronary interventionprerandomization treatment planquantitative flow ratio

Autor:innen und Institutionen

  • Cardiometabolic Medicine Center, National Clinical Research Center for Cardiovascular Diseases, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical C…
  • Department of Cardiology, National Clinical Research Center for Cardiovascular Diseases, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College,…
  • Catheterization Laboratories, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Department of Cardiology, Beijing Tiantan Hospital, Capital Medical University, Beijing China.
  • Department of Cardiology, Second Affiliated Hospital of Harbin Medical University, Harbin, China.
  • Department of Cardiology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China.

Förderung

  • CAMS
  • National Natural Science Foundation of China
  • Beijing Municipal Health Commission

Zitieren

APA

Zhang, R., Wang, H. Y., Song, L., Guan, C., Yin, D., Zhu, C., Feng, L., Jin, Z., Yu, B., Fu, G., Zhou, Y., Wang, J., Chen, Y., Pu, J., Chen, L., Qu, X., Zhao, Y., Wang, Y., Liu, W., …, & FAVOR III China Study Group (2026). Rationales Behind Physiology-Guided Revascularization. JACC: Cardiovascular Interventions. https://doi.org/10.1016/j.jcin.2025.10.042

Vancouver

Zhang R, Wang HY, Song L, Guan C, Yin D, Zhu C, et al. Rationales Behind Physiology-Guided Revascularization. JACC: Cardiovascular Interventions. 2026. doi:10.1016/j.jcin.2025.10.042

BibTeX
@article{Zhang2026,
  author = {Zhang, Rui and Wang, Hao-Yu and Song, Lei and Guan, Changdong and Yin, Dong and Zhu, Chenggang and Feng, Lei and Jin, Zening and Yu, Bo and Fu, Guosheng and Zhou, Yujie and Wang, Jian'an and Chen, Yundai and Pu, Jun and Chen, Lianglong and Qu, Xinkai and Zhao, Yanyan and Wang, Yang and Liu, Weida and Qiao, Shubin and Tu, Shengxian and Wijns, William and Dou, Kefei and FAVOR III China Study Group, FAVOR III China Study Group},
  title = {Rationales Behind Physiology-Guided Revascularization},
  journal = {JACC: Cardiovascular Interventions},
  year = {2026},
  doi = {10.1016/j.jcin.2025.10.042}
}
Kostenlos starten →